Predictive Oncology Inc. (POAI)
$5.95+0.51%Close
SELLCRISIS · day 44
Key stats
- Market cap
- $4M
- Beta
- 1.35
- P/E (TTM)
- -0.03
- 1W
- +8.58%
- 1M
- -9.16%
- vs SPY 1W
- +8.72%
- vs SPY 1M
- -11.67%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 40
- VALUE
- 26
- GROWTH
- 29
- GARP
- 86
- TYPE
- Growth Compounder
Composite of Value · Growth · GARP
ROIC-
REV YoY-
ROE-
EPS YoY-
ROA-235.4%
GROSS7
OP-1484
NET-7242
[VALUATION]
P/E TTM-0.03
P/E FWD1.37
SECTOR PE20.34
INDUSTRY PE45.85
P/B2.84
P/FCF-
EV/EBITDA0.07
EV/EBIT-
PEG0.01
FCF YIELD-
RISK
INT COV-
D/E3.65
ALTMAN Z-
CURR RATIO1.45
ND/EBITDA-
BETA1.35
Company news
FAQ
- What is LOPJLB’s current signal on POAI?
- LOPJLB’s latest quantitative signal on Predictive Oncology Inc. (POAI) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is POAI in?
- Predictive Oncology Inc. (POAI) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Predictive Oncology Inc. (POAI) do?
- Predictive Oncology Inc. (POAI), an organization driven by expertise and data, is dedicated to pioneering individualized cancer treatments through the application of artificial intelligence, primarily within the United States. The company conducts its operations across four distinct divisions: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics division offers extensive clinical diagnostic …